Pulse Biosciences
PLSE
Pulse Biosciences (PLSE) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.28
- EPS estimate
- −$0.29
- EPS surprise
- +3.00%
- Revenue surprise
- −18.62%
- Revenue
- $434,000.00
- Revenue estimate
- $533,333.00
- Reported
- Aug 6, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.29 | −$0.28 | +3.00% | $434,000.00 | SEC |
| Q1 2026 | May 4, 2026 | −$0.27 | −$0.24 | +11.81% | $400,000.00 | SEC |
| Q4 2025 | Feb 19, 2026 | −$0.27 | −$0.18 | +30.98% | $264,000.00 | SEC |
| Q3 2025 | Nov 5, 2025 | −$0.31 | −$0.20 | +34.58% | $86,000.00 | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.26 | −$0.20 | +23.54% | $0.00 | SEC |
| Q1 2025 | May 8, 2025 | $0.00 | −$0.17 | +0.00% | $0.00 | SEC |
| Q4 2024 | Mar 28, 2025 | −$0.24 | −$0.17 | +31.08% | $0.00 | SEC |
| Q3 2024 | Oct 30, 2024 | −$0.24 | −$0.16 | +34.83% | $0.00 | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.24 | −$0.20 | +16.67% | $0.00 | SEC |
| Q1 2024 | May 7, 2024 | −$0.24 | −$0.14 | +40.54% | $0.00 | SEC |
| Q4 2023 | Mar 28, 2024 | −$0.24 | −$0.15 | +35.96% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.24 | −$0.15 | +36.71% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.24 | −$0.22 | +8.33% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.22 | −$0.23 | −3.00% | $0.00 | SEC |
| Q4 2022 | Mar 30, 2023 | −$0.24 | −$0.22 | +7.96% | −$9,000.00 | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.45 | −$0.46 | −1.36% | $0.00 | SEC |
| Q2 2022 | Aug 10, 2022 | −$0.40 | −$0.37 | +5.62% | $265,000.00 | SEC |
| Q1 2022 | May 11, 2022 | −$0.52 | −$0.58 | −10.84% | $444,000.00 | SEC |
| Q4 2021 | Mar 31, 2022 | −$0.51 | −$0.52 | −1.96% | $844,000.00 | SEC |
| Q3 2021 | Nov 15, 2021 | −$0.53 | −$0.48 | +9.99% | $574,000.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Pulse Biosciences (PLSE) last report earnings?
Pulse Biosciences last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did PLSE beat earnings estimates?
Yes. Pulse Biosciences reported EPS of −$0.28 for Q2 2026 against a −$0.29 estimate — a 3.00% beat.
How much revenue did PLSE report last quarter?
Pulse Biosciences reported $434,000.00 in revenue for Q2 2026, against a consensus estimate of $533,333.00.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.